Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OneMedNet (ONMD) Gains from Investment Securities (2021 - 2025)

OneMedNet has reported Gains from Investment Securities over the past 5 years, most recently at $23000.0 for Q4 2025.

  • Quarterly Gains from Investment Securities fell 80.0% to $23000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $394000.0 through Dec 2025, up 228.33% year-over-year, with the annual reading at $518278.0 for FY2024, N/A changed from the prior year.
  • Gains from Investment Securities was $23000.0 for Q4 2025 at OneMedNet, down from $54000.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $728.6 million in Q4 2021 and troughed at -$2.8 million in Q1 2022.
  • The 5-year median for Gains from Investment Securities is $6000.0 (2024), against an average of $48.3 million.
  • Year-over-year, Gains from Investment Securities tumbled 100.03% in 2022 and then surged 5133.33% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $728.6 million in 2021, then tumbled by 100.03% to -$245217.0 in 2022, then crashed by 51.41% to -$371291.0 in 2023, then skyrocketed by 130.97% to $115000.0 in 2024, then crashed by 80.0% to $23000.0 in 2025.
  • Per Business Quant, the three most recent readings for ONMD's Gains from Investment Securities are $23000.0 (Q4 2025), $54000.0 (Q3 2025), and $314000.0 (Q2 2025).